MarketCapExport financials
Innospec (IOSP)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Innospec Balance Sheet 2025-2008 | IOSP
Brief overview of Innospec 's balance sheet strength
The balance sheet is assessed across five available annual reports spanning 2021 to 2025.
Assets increased from $1.6 billion to $1.8 billion, or +16.6%; CAGR of about 3.9% indicates steady balance sheet expansion.
Liabilities increased less than assets, posting -7.1% versus +16.6%. That relationship usually strengthens the balance sheet.
Equity funds 72.4% of assets versus 65.8% initially. This creates a conservative balance sheet structure.
Cash exceeds interest-bearing debt, producing net debt of -$239.8 million. The balance sheet therefore carries a net cash position.
Cash equals 16% of the balance sheet, compared with 9% five periods ago. This is the readily available cushion.
Retained earnings are $1.1 billion versus $822.9 million initially. The direction shows how results contributed to equity.
Overall assessment
The indicators point to a strong balance sheet position for Innospec : funding is balanced and liability risks appear controlled.
Annual Balance Sheet Innospec
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-240 M | -244 M | -158 M | -102 M | -106 M | - | 16.9 M | 84.5 M | 128 M | 167 M | 900 K | 97.8 M | 67.8 M | 7.6 M | -41.2 M | -60.1 M | - | - |
Long Term Debt |
36.8 M | 31 M | 31.6 M | 31.4 M | 23.1 M | - | 58.6 M | 186 M | 203 M | 258 M | 133 M | 139 M | 143 M | 25 M | 30 M | 32 M | - | - |
Long Term Debt Current |
15.9 M | 13.9 M | 13.6 M | 13.9 M | 12.4 M | 11.3 M | 10.6 M | 21.4 M | 15.8 M | 10.3 M | - | 400 K | 5.3 M | 5 M | 5 M | 15 M | - | - |
Total Non Current Liabilities |
139 M | 147 M | 186 M | 158 M | 201 M | 200 M | 246 M | 351 M | 354 M | 344 M | 219 M | 261 M | 230 M | 115 M | 79.7 M | - | - | - |
Total Current Liabilities |
360 M | 371 M | 372 M | 406 M | 337 M | 252 M | 304 M | 297 M | 262 M | 183 M | 206 M | 223 M | 156 M | 147 M | 146 M | 159 M | - | - |
Total Liabilities |
500 M | 519 M | 558 M | 563 M | 538 M | 452 M | 550 M | 648 M | 616 M | 528 M | 425 M | 484 M | 385 M | 262 M | 226 M | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | 100 K | 100 K | 200 K | 200 K | 300 K | 1.4 M | 1.4 M | - | - | - |
Retained Earnings |
1.1 B | 1.02 B | 1.03 B | 924 M | 823 M | 759 M | 756 M | 668 M | 605 M | 562 M | 496 M | 392 M | 328 M | 281 M | 259 M | 194 M | - | - |
Total Assets |
1.83 B | 1.73 B | 1.71 B | 1.6 B | 1.57 B | 1.4 B | 1.47 B | 1.47 B | 1.41 B | 1.18 B | 1.03 B | 1 B | 795 M | 579 M | 569 M | 549 M | - | - |
Cash and Cash Equivalents |
292 M | 289 M | 204 M | 147 M | 142 M | 105 M | 75.7 M | 123 M | 90.2 M | 102 M | 137 M | 41.6 M | 80.2 M | 22.4 M | 76.2 M | 107 M | 68.6 M | 13.9 M |
Book Value |
1.33 B | 1.22 B | 1.15 B | 1.04 B | 1.03 B | 945 M | 919 M | 826 M | 794 M | 654 M | 605 M | 516 M | 409 M | 317 M | 343 M | 549 M | - | - |
Total Shareholders Equity |
1.33 B | 1.21 B | 1.15 B | 1.04 B | 1.03 B | 944 M | 918 M | 825 M | 794 M | 654 M | 605 M | 516 M | 409 M | 317 M | 343 M | 301 M | 158 M | 229 M |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet Innospec
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
33.8 M | 33.6 M | 35.5 M | 36.8 M | 33 M | 33.7 M | 30.4 M | 31 M | 31.7 M | 33.2 M | 30 M | 31.6 M | 29.4 M | 31.6 M | 33.8 M | 31.4 M | 32.1 M | 35.2 M | 28.3 M | 23.1 M | 20.2 M | 24.4 M | - | 28.9 M | - | 38.8 M | 58.7 M | 21.9 M | 22.8 M | 24.4 M | 26 M | 186 M | 224 M | 224 M | 214 M | 218 M | 229 M | 249 M | 239 M | 269 M | 143 M | 154 M | 146 M | 132 M | 127 M | 139 M | 139 M | 139 M | 115 M | 140 M | 140 M | 148 M | 143 M | 33 M | 143 M | 30 M | 25 M | 25 M | 25 M | 35 M | 30 M | 30 M | 30 M |
Total Non Current Liabilities |
125 M | 127 M | 133 M | 139 M | 140 M | 167 M | 151 M | 147 M | 177 M | 172 M | 182 M | 186 M | 146 M | 151 M | 162 M | 158 M | 196 M | 200 M | 203 M | 201 M | - | - | - | - | - | - | - | - | 316 M | 323 M | 378 M | 351 M | 366 M | 364 M | 356 M | 354 M | 327 M | 344 M | 327 M | 344 M | 232 M | 242 M | 234 M | 219 M | 232 M | 255 M | 265 M | 261 M | 196 M | 220 M | 357 M | 230 M | - | 256 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
476 M | 495 M | 468 M | 500 M | 496 M | 505 M | 509 M | 519 M | 550 M | 504 M | 547 M | 558 M | 490 M | 516 M | 544 M | 563 M | 577 M | 569 M | 555 M | 538 M | - | - | - | - | - | - | - | - | 612 M | 626 M | 678 M | 648 M | 657 M | 632 M | 648 M | 616 M | 565 M | 572 M | 549 M | 528 M | 391 M | 392 M | 382 M | 425 M | 429 M | 449 M | 455 M | 484 M | 317 M | 346 M | 484 M | 385 M | - | 385 M | - | - | - | - | - | - | - | - | - |
Retained Earnings |
1.17 B | 1.14 B | 1.13 B | 1.1 B | 1.07 B | 1.06 B | 1.06 B | 1.02 B | 1.12 B | 1.08 B | 1.07 B | 1.03 B | 1.01 B | 969 M | 957 M | 924 M | 915 M | 876 M | 859 M | 823 M | 814 M | 790 M | 782 M | 759 M | 759 M | 759 M | 789 M | 756 M | 737 M | 707 M | 697 M | 668 M | 659 M | 638 M | 627 M | 605 M | 619 M | 596 M | 579 M | 562 M | 548 M | 536 M | 515 M | 496 M | 472 M | 437 M | 410 M | 392 M | 377 M | 356 M | 344 M | 320 M | 328 M | 316 M | 328 M | 262 M | 281 M | 281 M | 281 M | 242 M | 259 M | 259 M | 259 M |
Total Assets |
1.86 B | 1.85 B | 1.82 B | 1.83 B | 1.8 B | 1.81 B | 1.77 B | 1.73 B | 1.8 B | 1.7 B | 1.73 B | 1.71 B | 1.62 B | 1.61 B | 1.62 B | 1.6 B | 1.67 B | 1.64 B | 1.62 B | 1.57 B | 1.49 B | 1.46 B | 1.43 B | 1.4 B | 1.4 B | 1.4 B | 1.46 B | 1.47 B | 1.49 B | 1.49 B | 1.53 B | 1.47 B | 1.5 B | 1.45 B | 1.47 B | 1.41 B | 1.31 B | 1.28 B | 1.23 B | 1.18 B | 1.04 B | 1.03 B | 1 B | 1.03 B | 1.02 B | 998 M | 977 M | 1 B | 775 M | 787 M | 778 M | 795 M | 795 M | 594 M | 795 M | 579 M | 579 M | 579 M | 579 M | 569 M | 569 M | 569 M | 569 M |
Cash and Cash Equivalents |
252 M | 250 M | 289 M | 292 M | 271 M | 267 M | 300 M | 289 M | 304 M | 240 M | 270 M | 204 M | 207 M | 166 M | 148 M | 147 M | 100 M | 71.4 M | 106 M | 142 M | 89.2 M | 94.4 M | 117 M | 105 M | 105 M | 105 M | 68.1 M | 75.7 M | 110 M | 106 M | 124 M | 123 M | 91.4 M | 66 M | 78.1 M | 90.2 M | 65.5 M | 48.8 M | 45.4 M | 102 M | 167 M | 153 M | 113 M | 137 M | 128 M | 64.3 M | 46.5 M | 41.6 M | 90.4 M | 91.4 M | 90.1 M | 80.2 M | 80.2 M | 54.7 M | 80.2 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 76.2 M | 76.2 M | 76.2 M | 76.2 M |
Book Value |
1.38 B | 1.35 B | 1.35 B | 1.33 B | 1.3 B | 1.3 B | 1.27 B | 1.22 B | 1.25 B | 1.2 B | 1.19 B | 1.15 B | 1.13 B | 1.09 B | 1.08 B | 1.04 B | 1.09 B | 1.07 B | 1.07 B | 1.03 B | 1.49 B | 1.46 B | 1.43 B | 1.4 B | 1.4 B | 1.4 B | 1.46 B | 1.47 B | 882 M | 863 M | 849 M | 826 M | 840 M | 820 M | 825 M | 794 M | 748 M | 704 M | 676 M | 654 M | 652 M | 640 M | 619 M | 604 M | 588 M | 550 M | 522 M | 516 M | 458 M | 441 M | 294 M | 409 M | 795 M | 209 M | 795 M | 579 M | 579 M | 579 M | 579 M | 569 M | 569 M | 569 M | 569 M |
Total Shareholders Equity |
1.38 B | 1.35 B | 1.35 B | 1.33 B | 1.3 B | 1.3 B | 1.27 B | 1.22 B | 1.25 B | 1.2 B | 1.19 B | 1.15 B | 1.13 B | 1.09 B | 1.08 B | 1.04 B | 1.09 B | 1.07 B | 1.07 B | 1.03 B | 993 M | 974 M | 959 M | 945 M | 944 M | 944 M | 944 M | 919 M | 882 M | 863 M | 849 M | 826 M | 840 M | 820 M | 825 M | 794 M | 748 M | 704 M | 676 M | 654 M | 652 M | 640 M | 619 M | 605 M | 588 M | 550 M | 522 M | 516 M | 458 M | 441 M | 427 M | 409 M | 409 M | 352 M | 409 M | 317 M | 317 M | 317 M | 317 M | 343 M | 343 M | 343 M | 343 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of Innospec , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Specialty chemicals
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Gulf Resources
GURE
|
- | -2.8 % | $ 44.6 M |  China |
 |
International Flavors & Fragrances
IFF
|
$ 82.7 | -4.22 % | $ 21.2 B |  USA |
 |
Quaker Chemical Corporation
KWR
|
$ 151.24 | -0.07 % | $ 2.64 B | USA |
 |
Linde PLC
LIN
|
$ 515.27 | -1.14 % | $ 242 B |  Britain |
 |
LyondellBasell Industries N.V.
LYB
|
$ 60.96 | -1.08 % | $ 19.6 B |  Niderland |
 |
Northern Technologies International Corporation
NTIC
|
$ 7.53 | -0.66 % | $ 71.4 M | USA |
 |
PPG Industries
PPG
|
$ 122.47 | -0.65 % | $ 27.7 B | USA |
 |
Stepan Company
SCL
|
$ 67.15 | -0.44 % | $ 1.54 B | USA |
 |
The Sherwin-Williams Company
SHW
|
$ 344.44 | -1.33 % | $ 85.3 B | USA |
 |
SenesTech
SNES
|
$ 1.09 | -6.84 % | $ 3.57 M | USA |
 |
Sensient Technologies Corporation
SXT
|
$ 119.19 | -0.46 % | $ 5.03 B | USA |
 |
Crown ElectroKinetics Corp.
CRKN
|
- | -16.67 % | $ 15.5 M | USA |
 |
Tredegar Corporation
TG
|
$ 5.41 | -23.37 % | $ 188 M | USA |
 |
Element Solutions Inc
ESI
|
$ 31.41 | 2.11 % | $ 7.6 B | USA |
 |
Gevo
GEVO
|
$ 1.39 | 13.52 % | $ 325 M | USA |
 |
Westlake Chemical Corporation
WLK
|
$ 63.61 | -4.04 % | $ 8.16 B | USA |
 |
Venator Materials PLC
VNTR
|
- | - | $ 5.4 M | Britain |
 |
Chase Corporation
CCF
|
- | -0.01 % | $ 1.2 B | USA |
 |
GCP Applied Technologies
GCP
|
- | - | $ 2.37 B | USA |
 |
Amyris
AMRS
|
- | -21.88 % | $ 16 M | USA |
 |
Ingevity Corporation
NGVT
|
$ 59.97 | -5.91 % | $ 2.17 B | USA |
 |
Trecora Resources
TREC
|
- | 0.41 % | $ 231 M | USA |
 |
Livent Corporation
LTHM
|
- | - | $ 2.84 B | USA |
 |
Oil-Dri Corporation of America
ODC
|
$ 71.12 | 4.06 % | $ 1.03 B | USA |
 |
WD-40 Company
WDFC
|
$ 221.65 | -2.5 % | $ 2.99 B | USA |
 |
Cabot Corporation
CBT
|
$ 71.11 | -2.51 % | $ 3.82 B | USA |
 |
Albemarle Corporation
ALB
|
$ 99.03 | 0.72 % | $ 11.7 B | USA |
 |
Avantor
AVTR
|
$ 15.46 | 2.15 % | $ 10.5 B | USA |
 |
Balchem Corporation
BCPC
|
$ 174.22 | -3.05 % | $ 5.62 B | USA |
 |
Ecolab
ECL
|
$ 300.69 | -1.57 % | $ 85.2 B | USA |
 |
Axalta Coating Systems Ltd.
AXTA
|
$ 36.46 | 0.33 % | $ 7.88 B | USA |
 |
The Chemours Company
CC
|
$ 12.72 | -0.27 % | $ 1.91 B | USA |
 |
Avient Corporation
AVNT
|
$ 45.55 | 0.46 % | $ 4.17 B | USA |
 |
Green Plains
GPRE
|
$ 13.24 | -3.39 % | $ 894 M | USA |
 |
Core Molding Technologies
CMT
|
$ 21.59 | 2.57 % | $ 185 M | USA |
 |
Hawkins
HWKN
|
$ 152.61 | 0.4 % | $ 3.16 B | USA |
 |
H.B. Fuller Company
FUL
|
$ 49.89 | -0.65 % | $ 2.72 B | USA |
 |
Hudson Technologies
HDSN
|
$ 4.18 | 2.32 % | $ 182 M | USA |
 |
PQ Group Holdings Inc.
PQG
|
- | 0.58 % | $ 2.14 B | USA |
 |
Koppers Holdings
KOP
|
$ 29.86 | -24.71 % | $ 593 M | USA |
 |
Orion Engineered Carbons S.A.
OEC
|
$ 3.94 | -5.52 % | $ 222 M |  Luxembourg |
 |
NewMarket Corporation
NEU
|
$ 693.22 | -0.02 % | $ 6.51 B | USA |
 |
Loop Industries
LOOP
|
$ 0.25 | 0.68 % | $ 12 M |  Canada |
 |
Olin Corporation
OLN
|
$ 17.31 | -4.18 % | $ 1.98 B | USA |
 |
Kronos Worldwide
KRO
|
$ 7.46 | 5.22 % | $ 858 M | USA |
 |
RPM International
RPM
|
$ 103.54 | -1.79 % | $ 13.2 B | USA |
 |
Ferro Corporation
FOE
|
- | 0.27 % | $ 1.84 B | USA |
 |
W. R. Grace & Co.
GRA
|
- | 0.03 % | $ 4.64 B | USA |
 |
IKONICS Corporation
IKNX
|
- | -5.44 % | $ 57.2 M | USA |